Transfection Reagents and Equipment market is expected to grow from USD 10.46 billion in 2019 to USD 17.87 billion by 2026 at a CAGR of 7.95% from 2020 to 2026.
Transfection is a technique that is employed to insert genetic material like DNA or RNA, into mammalian cells. Transfection reagents and equipment are utilized in this process, wherein reagents contain the genetic material and equipment used as a delivery for the genetic material. This introduction of genetic material into the specified cells are often administered by various chemical, biological, or physical methods. The growth of the market is often attributed to increasing technological advancements in transfections equipment and rising research and development spending alongside research activities by pharmaceutical and biotechnology companies. Moreover, rising demand for synthetic genes is probably going to feature new opportunities for the worldwide market within the forecast period. This growth is often attributed to factors like advancements in transfection technology, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer. Moreover, the development of huge scale transfections, rising demand for protein therapeutics, and emerging markets across India and China are likely to make opportunities for players operating within the market. The global market is segregated on the basis of Product as Reagents and Instruments.
View Complete Report: @ https://marketreportslibrary.com/report/he0245/transfection-reagents-and-equipment-market
The global Transfection Reagents and Equipment market has been segmented as below:
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Gene Expression Studies
Rest of The World
Thermo Fisher Scientific Inc. (Life Technologies), Promega Corporation, Qiagen N.V., F. Hoffmann-La Roche Ltd, Bio–Rad Laboratories, Inc., Maxcyte, Inc., Lonza Group Ltd., Merck KGaA, Polyplus-Transfection Sa, Mirus Bio LLC., and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
Request a Sample of this Report: @ https://marketreportslibrary.com/request/sample/he0245/transfection-reagents-and-equipment-market
Explore other reports from ”Healthcare” sector @ https://marketreportslibrary.com/category/healthcare
SRR residency Mig-59,
7th phase Kphb colony
Near prathibha school